Skip to main content

Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

CBE ID
0389
1.4 Project
Cancer
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2022
Is Under Review
No
1.3 Measure Description

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer

    • 1.14 Numerator

      Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer

    • 1.15 Denominator

      All patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy

    • Exclusions

      Denominator Exceptions:
      Documentation of medical reason(s) for having a bone scan performed (including documented pain, salvage therapy, other medical reasons)

      Documentation of system reason(s) for having a bone scan performed (including bone scan ordered by someone other than reporting physician)

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cancer Fall Cycle 2022
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Centers for Medicare & Medicaid Services
      Steward Organization Email
      [email protected]
      Steward Organization Copyright

      The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications.

      The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, e.g., use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain.

      Commercial uses of the Measures require a license agreement between the user and the American Medical Association (AMA). Neither the American Medical Association (AMA), nor the AMA-convened Physician Consortium for Performance Improvement® (AMA-PCPI), now known as the PCPI, nor their members shall be responsible for any use of the Measures.

      AMA encourages use of the Measures by other health care professionals, where appropriate.

      THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.

      © 2015 American Medical Association. All Rights Reserved.

      Limited proprietary coding is contained in the Measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. The AMA, the PCPI and its members and former members of the AMA-PCPI disclaim all liability for use or accuracy of any Current Procedural Terminology (CPT®) or other coding contained in the specifications.

      CPT® contained in the Measures specifications is copyright 2004-2015 American Medical Association. LOINC® copyright 2004-2015 Regenstrief Institute, Inc. SNOMED CLINICAL TERMS (SNOMED CT®) copyright 2004-2015 The International Health Terminology Standards Development Organisation (IHTSDO). ICD-10 is copyright 2015 World Health Organization. All Rights Reserved.